Role of topoisomerase IIβ in the resistance of 9-OH-ellipticine- resistant Chinese hamster fibroblasts to topoisomerase II inhibitors

Cancer Research

Volumn 57, Issue 19, 1997, Pages 4301-4308

  Dereuddre, Sophie ^a   Delaporte, Charlotte ^a   Jacquemin Sablon, Alain ^a,b  

^a CNRS   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

9 HYDROXYELLIPTICINE; AMSACRINE; DNA TOPOISOMERASE (ATP HYDROLYSING); ETOPOSIDE; GYRASE INHIBITOR; ISOENZYME;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CANCER RESISTANCE; CELL SURVIVAL; CHINESE HAMSTER; COMPLEX FORMATION; CYTOTOXICITY; DNA TRANSFECTION; ENZYME ACTIVITY; FIBROBLAST CULTURE; GENE MUTATION; NONHUMAN; PRIORITY JOURNAL;

AMSACRINE; ANIMALS; CELL LINE; CODON; CRICETINAE; CRICETULUS; DNA TOPOISOMERASES, TYPE II; DRUG RESISTANCE, NEOPLASM; ELLIPTICINES; ENZYME INHIBITORS; ETOPOSIDE; FIBROBLASTS; GENISTEIN; ISOENZYMES; LUNG;

EID: 0030845812     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Wang, J. C. DNA topoisomerases. Annu. Rev. Biochem., 54: 665-697, 1985.
2. Vosberg, H-P. DNA topoisomerases: enzymes that control DNA conformation. Curr. Top. Microbiol. Immunol., 114: 19-102, 1985.
3. Yanagida, M., and Sternglanz, R. Genetics of DNA topoisomerase. In: N. R. Cozzarelli and J. C. Wang (eds.), DNA Topology and Its Biological Effects, pp. 299-300. Plainview, NY: Cold Spring Harbor Laboratory, 1990.
4. Drake, F. H., Zimmerman, J. P., McCabe, F. L., Bartus, H. F., Per, S. R., Sullivan, D. M., Ross, W. E., Mattern, M. R., Johnson, R. K., Crooke, S. T., and Mirabelli, C. K. Purification of topoisomerase II from amsacrine resistant P388 leukemia cells: evidence for two forms of the enzyme. J. Biol. Chem., 262: 16739-16747, 1987.
5. Chung, T. D. Y., Drake, F. H., Tan, K. B., Per, S. R., Crooke, S. T., and Mirabelli, C. K. Characterization and immunological identification of cDNA clones encoding two human DNA topoisomerase II isozymes. Proc. Natl. Acad. Sci. USA, 86: 9431-9435, 1989.
6. Tan, K. B., Dorman, T. E., Falls, K. M., Chung, T. D. Y., Mirabelli, C. K., Crooke, S. T., and Mao, J. Topoisomerase IIα and topoisomerase IIβ genes: characterization and mapping to human chromosomes 17 and 3 respectively. Cancer Res., 48: 3230-3235, 1992.
7. Woessner, R. D., Mattern, M. R., Mirabelli, C. K., Johnson, R. K., and Drake, F. H. Proliferation- and cell cycle-dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH-3T3 cells. Cell Growth Differ., 2: 209-214, 1991.
8. Goswami, P. C., Roti-Roti, J. L., and Hunt, C. R. The cell cycle expression of topoisomerase IIα during S phase is regulated by mRNA stability and is disrupted by heat shock or ionizing radiation. Mol. Cell. Biol., 16: 1500-1508, 1996.
9. Meyer, K. N., Kjeldsen, E., Straub, T., Knudsen, B. R., Hickson, I. D., Kikuchi, A., Kreipe, H., and Boege, F. Cell cycle-coupled relocation of types I and II topoisomerases and modulation of catalytic enzyme activities. J. Cell Biol. 24: 775-788, 1997.
10. Drake, F. H., Hofman, G. A., Bartus, H. F., Mattern, M. R., Crooke, S. T., and Mirabelli, C. K. Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II. Biochemistry, 28: 8154-8160, 1989.
11. Capranico, G., Tinelli, S., Austin, A. A., Fischer, M. L., and Zunino, F. Different patterns of gene expression of topoisomerase II isoforms in differentiated tissues during murine development. Biochem. Biophys. Acta. 1132: 43-48, 1992.
12. Zini, N., Martelli, A. M., Sabatelli, P., Santi, S., Negri, C., Astaldi Ricotti, G. C. B., and Maraldi, N. M. The 180-kDa isoform of topoisomerase II is localized in the nucleus and belongs to the structural elements of the nuclear remnant. Exp. Cell Res., 200: 460-466, 1992.
13. Juenke, J. M., and Holden, J. A. The distribution of DNA topoisomerase II isoforms in differentiated adult tissues. Biochem. Biophys. Acta. 1216: 191-196, 1993.
14. Negri, C., Scovassi, A. I., Braghetti, A., Guano, F., and Astaldi Ricotti, G. C. B. DNA topoisomerase II β: stability and distribution in different animal cells in comparison to topoisomerase I and IIα. Exp. Cell Res., 206: 128-133, 1993.
15. Tsutsui, K., Tsutsui, K., Okada, S., Watanabe, M., Shohmori, T., Seki, S., and Inoue, Y. Molecular cloning of partial cDNAs from rat DNA topoisomerase II isoforms and their differential expression in brain development. J. Biol. Chem., 268: 19076-19083, 1993.
16. Liu, L. F., DNA topoisomerase poisons as antitumor drugs. Annu. Rev. Biochem., 58: 351-375, 1989.
17. Liu, L. F., Rowe, T. C., Yang, L., Towey, K. M., and Chen, G. L. Reversible DNA strand cleavage by mammalian DNA topoisomerase II. J. Biol. Chem., 258: 15365-15370, 1983.
18. Salles, B., Charcosset, J-Y., and Jacquemin-Sablon, A. Isolation and properties of Chinese hamster lung cells resistant to ellipticine derivatives. Cancer Treat. Rep., 66: 327-338, 1982.
19. Jacquemin-Sablon, A., Bojanowski, K., Casabianca-Pignède, M-R., Crémier, S., Delaporte, C., Khélifa, T., René, B., Saucier, J-M., and Larsen, A. K. Phenotypic properties of Chinese hamster lung cells resistant to DNA topoisomerase II inhibitors. In: T. Andoh, H. Ikeda, and M. Oguro (eds.), Molecular Biology of DNA Topoisomerases and Its Application to Chemotherapy, pp. 265-273. Tokyo: CRC Press, 1993.
20. Pommier, Y., Schwartz, R. E., Zwelling, L. A., Kerrigan, D., Mattern, M. R., Charcosset, J-Y., Jacquemin-Sablon, A., and Kohn, K. W. Reduced formation of protein-associated DNA strand breaks in Chinese hamster cells resistant to topoisomerase II inhibitors. Cancer Res., 46: 611-616, 1986
21. Charcosset, J-Y., Saucier, J-M., and Jacquemin-Sablon, A. Reduced DNA topoisomerase II activity and drug-stimulated DNA cleavage in 9-hydroxyellipticine resistant cells. Biochem. Pharmacol., 37: 2145-2149, 1988.
22. Khélifa, T., Casabianca-Pignède, M-R., René, B., and Jacquemin-Sablon, A. Expression of topoisomerase IIα and β in Chinese hamster lung cells resistant to topoisomerase II inhibitors. Mol. Pharmacol., 46: 323-328, 1994.
23. Dereuddre, S., Frey, S., Delaporte, C., and Jacquemin-Sablon, A. Cloning and characterization of full length cDNAs coding for the DNA topoisomerase IIβ from Chinese hamster lung cells sensitive and resistant to 9-OH-ellipticine. Biochem. Biophys. Acta. 1264: 178-182, 1995.
24. Nicolas, J-F., and Berg, P. Regulation of expression of genes transduced into embryonal carcinoma cells. In: L. M. Silver, G. R. Martin, and S. Strickland (eds.), Cold Spring Harbor Conferences on Cell Proliferation - Teratoma Stem Cells, Vol. 10, pp. 469-485. Plainview, NY: Cold Spring Harbor Laboratory, 1983.
25. Chen, C., and Okoyama, H., High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol., 7: 2745-2752, 1987.
26. Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., and Rutter, W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry, 18: 5294-5299, 1979.
27. Riou, J-F., Helissey, P., Grondard, L., and Giorgy-Renault, S. Inhibition of eukaryotic DNA topoisomerase I and II activities by indoloquinolidione derivatives. Mol. Pharmacol., 40: 699-706, 1991.
28. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72: 248-254, 1976.
29. Froelich-Ammon, S. J., and Osheroff, N. Topoisomerase poisons: harnessing the dark side of enzyme mechanism. J. Biol. Chem., 270: 21429-21432, 1995.
30. Nitiss, J. L., and Beck, W. T. Antitopoisomerase drug action and resistance. Eur. J. Cancer, 32A: 958-966, 1996.
31. Worland, S. T., and Wang, J. C. Inducible overexpression, purification, and active site mapping of DNA topoisomerase II from the yeast Saccharomyces rerevisiae. J. Biol. Chem., 264: 4412-4416, 1989.
32. Eder, J. P., Chan, V. T-W., Niemierko, E., Teicher, B. A., and Schnipper, L. E. Conditional expression of wild-type topoisomerase II complements a mutant enzyme in mammalian cells. J. Biol. Chem., 268: 13844-13849, 1993.
33. Asano, T., An, T., Mayest, J., Zwelling, L. A., and Kleinerman, E. S. Transfection of human topoisomerase IIα into etoposide-resistant cells: transient increase in sensitivity followed by down-regulation of the endogenous gene. Biochem. J., 319: 307-313, 1995.
34. Austin, C. A., Marsh, K. L., Wasserman, R. A., Willmore, E., Sayer, P. J., Wang, J. C., and Fisher, M. L. Expression, domain structure, and enzymatic properties of an active recombinant human DNA topoisomerase IIβ. J. Biol. Chem., 270: 15739-15746, 1995.
35. Meczes, E. L., Marsh, K. L., Fisher, L. M., Rogers, M. P., and Austin, C. A. Complementation of temperature-sensitive topoisomerase II mutations in Saccharomyces cerevisiae by a human TOP2β construct allows the study of topoisomerase IIβ inhibitors in yeast. Cancer Chemother. Pharmacol., 39: 367-375, 1997.
36. Pommier, Y., Orr, A., Kohn, K. W., and Riou, J-F. Differential effects of amsacrine and epipodophyllotoxins on topoisomerase II cleavage in the human c-myc oncogene. Cancer Res., 52: 3125-3130, 1992.
37. Houlbrook, S., Addison, C. M., Davies, S. L., Carmichael, J., Stratford, I. J., Harris, A. L., and Hickson, I. D. Relationship between expression of topoisomerase II isoforms and intrinsic sensitivity to topoisomerase II inhibitors in breast cancer cell lines. Br. J. Cancer, 72: 1454-1461, 1995.
38. Brown, G. A., McPherson, J. P., Gu, L., Medley, D. W., Toso, R., Deuchars, K. L., Freedman, M. H., and Goldenberg, G. H. Relationship of DNA topoisomerase IIα and β expression to cytotoxicity of antineoplasic agents in human acute lymphoblastic leukemia cell lines. Cancer Res., 55: 78-82, 1995.
39. Marsh, K. L., Willmore, E., Tinelli, S., Cornarotti, M., Meczes, E. L., Capranico, G., Fisher, L. M., and Austin, C. Amsacrine-promoted DNA cleavage site determinants for the two human DNA topoisomerase II isoforms α and β. Biochem. Pharmacol., 52: 1675-1685, 1996.
40. Qiu, J., Catapano, C. V., and Fernandes, D. J. Formation of topoisomerase IIα complexes with nascent DNA is related to VM-26-induced cytotoxicity. Biochemistry, 35: 16354-16360, 1996.
41. Withoff, S., de Vries, E., Keith, W. N., Nienhuis, E. F., van der Graaf, W. T. A., Uges, D. R. A., and Mulder, N. H. Differential expression of DNA topoisomerase IIα and -β in P-gp and MRP-negative VM26, mAMSA, and mitoxanthrone-resistant sublines of the human SCLC cell line GLC4. Br. J. Cancer, 74: 1869-1876, 1996.